Identifying Viral Infections through Analysis of Head space Volatile Organic Compounds.

Influenza in vitro seasonal corona viruses volatile organic compunds

Journal

Journal of breath research
ISSN: 1752-7163
Titre abrégé: J Breath Res
Pays: England
ID NLM: 101463871

Informations de publication

Date de publication:
22 Oct 2024
Historique:
medline: 23 10 2024
pubmed: 23 10 2024
entrez: 22 10 2024
Statut: aheadofprint

Résumé

Volatile organic compounds (VOCs) produced by human respiratory cells reflect metabolic and pathophysiological processes which can be detected with the use of modern technology. Analysis of exhaled breath or indoor air may potentially play an important role in screening of upper respiratory tract infections such as COVID-19 or influenza in the future.
Methods: In this experimental study, air samples were collected and analyzed from the headspace of an in vitro cell culture infected by selected pathogens (Influenza A H1N1 and seasonal coronaviruses OC43 and NL63). VOCs were measured with a real-time proton-transfer-reaction time-of-flight mass spectrometer and a differential mobility spectrometer. Measurements were performed every 12 hours for 7 days. Non-infected cells and cell culture media served as references.
Results: In H1N1 and OC43 we observed four different VOCs which peaked during the infection. Different, individual VOCs were also observed in both infections. Activity began to clearly increase after 2 days in all analyses. We did not see increased VOC production in cells infected with NL63.
Discussion: VOC analysis seems to be suitable to differentiate the infected cells from those which are not infected as well as different viruses, from another. In the future, this could have practical value in both individual diagnostics and indoor environment screening.&#xD.

Sections du résumé

BACKGROUND BACKGROUND
Volatile organic compounds (VOCs) produced by human respiratory cells reflect metabolic and pathophysiological processes which can be detected with the use of modern technology. Analysis of exhaled breath or indoor air may potentially play an important role in screening of upper respiratory tract infections such as COVID-19 or influenza in the future.
Methods: In this experimental study, air samples were collected and analyzed from the headspace of an in vitro cell culture infected by selected pathogens (Influenza A H1N1 and seasonal coronaviruses OC43 and NL63). VOCs were measured with a real-time proton-transfer-reaction time-of-flight mass spectrometer and a differential mobility spectrometer. Measurements were performed every 12 hours for 7 days. Non-infected cells and cell culture media served as references.
Results: In H1N1 and OC43 we observed four different VOCs which peaked during the infection. Different, individual VOCs were also observed in both infections. Activity began to clearly increase after 2 days in all analyses. We did not see increased VOC production in cells infected with NL63.
Discussion: VOC analysis seems to be suitable to differentiate the infected cells from those which are not infected as well as different viruses, from another. In the future, this could have practical value in both individual diagnostics and indoor environment screening.&#xD.

Identifiants

pubmed: 39437816
doi: 10.1088/1752-7163/ad89f0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Creative Commons Attribution license.

Auteurs

Enni Sanmark (E)

Department of ear-nose and throat disease, head and neck surgery, Helsinki University hospital and Helsinki University, Kasarmikatu 11-13, Helsinki, 00250, FINLAND.

Petteri Marjanen (P)

Aerosol Physics Laboratory, Physics Unit, Faculty of Engineering and Natural Sciences, Tampere University, Tampere, Finland , Tampere University, Tampere, 33100, FINLAND.

Jenni Virtanen (J)

Department of Veterinary Biosciences, Faculty of Veterinary Medicine And Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland , Haartmaninkatu 3, Helsinki, 00280, FINLAND.

Kirsi Aaltonen (K)

Department of Veterinary Biosciences, Faculty of Veterinary Medicine And Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland , Haartmaninkatu 3, Helsinki, 00280, FINLAND.

Sisko Tauriainen (S)

Institute of Biomedicine, University of Turku, Turku, Finland, Turku University, Turku, 20014, FINLAND.

Pamela Österlund (P)

Finnish Institute for Health and Welfare, Helsinki, Finland, Terveyden ja Hyvinvoinnin laitos, Helsinki, 00280, FINLAND.

Meri Makela (M)

Olfactomics Oy, Tampere, Finland , Korkeakoulunkatu 7, Tampere, 33700, FINLAND.

Sampo Saari (S)

Tampere University of Applied Sciences, Tampere, Finland, Tampere University, Tampre, 33700, FINLAND.

Antti Roine (A)

Olfactomics Oy, Tampere, Finland , Korkeakoulunkatu 7, Tampere, 33700, FINLAND.

Topi Rönkkö (T)

Tampere University, Tampere University, Tampere, 33700, FINLAND.

Ville Vartiainen (V)

Heart and Lung center, Helsinki University Hospital, Helsinki, Finland, Helsinki University Hospital, Helsinki, 00280, FINLAND.

Classifications MeSH